Medicare Advantage plans are based on an enrollee's diagnosis; those with more serious or chronic conditions receive higher payments.

President Donald Trump and his White House have repeatedly vowed to protect Medicare and block any cuts to the vital health care program that serves 67 million Americans—most of them seniors. But according to top Democrats citing a report from the Congressional Budget Office,

The Trump administration has put in motion its plan to secure lower prescription drug costs for Americans. This week, the Trump administration took its first steps to implement what’s called "most-favored-nation" pricing.

The order is based on a "most favored nation" pricing model, which is similar to a policy Trump pushed in his first administration.

Medicaid might not be the “third rail” of American politics in the way that Social Security benefits are, but it could be the proverbial Costco hot dog.

President Donald Trump is expected to sign an executive order soon to lower the cost of prescription drugs for Medicare beneficiaries. The order would implement a “most favored nation” policy, tying the prices of certain Medicare-covered drugs to those paid by other developed countries.

A number of special government employees for DOGE — led by Elon Musk — have worked for the Tesla CEO's companies, which are regulated by the government.

Trump's plan to lower Medicare drug costs by aligning U.S. prices with other countries faces legal and industry challenges.

Donald Trump’s so-called One Big Beautiful Bill Act, as passed by House Republicans, would trigger automatic Medicare cuts.